Log in or Sign up for Free to view tailored content for your specialty!
Mood Disorders News
Cariprazine reduces depressive symptoms in bipolar depression
In a phase 3 study, cariprazine, both taken at 1.5 mg per day and 3 mg per day, was more effective than placebo in improving depressive symptoms in adults with bipolar I depression.
More teens, young adults report mental health issues vs. 10 years ago
Rates of serious psychological distress, major depression, suicidal thoughts, attempted suicide and completed suicide have increased between 2005 and 2017 among U.S. teenagers and young adults, according to National Survey on Drug Use and Health data.
Log in or Sign up for Free to view tailored content for your specialty!
Social anxiety disorder predicts alcohol use disorder
Unlike other anxiety disorders, social anxiety disorder appeared to have a causal association with alcohol use disorder in a study of nearly 3,000 adult twins.
FDA approves esketamine nasal spray for hard-to-treat depression
The FDA has approved esketamine nasal spray, combined with an oral antidepressant, for the treatment of adults with treatment-resistant depression, according to a press release.
Severity, variability of depression symptoms predict suicide attempt
Only the trajectory of depression symptoms that demonstrated the highest mean scores and variability over time predicted suicide attempt in high-risk young adults, according to a study analyzing the most important clinical predictors of suicide attempt.
CBT, pharmacotherapy equally effective for remission in depression
Study findings published in the American Journal of Psychiatry indicated that cognitive behavioral therapy and antidepressant medication appeared equally efficacious for achieving remission when sequentially combined in patients with nonremitting depression.
FDA committees support esketamine nasal spray for treatment-resistant depression
In a joint meeting, the FDA Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee recommended the approval of esketamine nasal spray CIII for adults with treatment-resistant depression, according to a press release.
Tamoxifen shows promise for mania episodes in bipolar disorder
Tamoxifen — a drug commonly used for breast cancer — shows potential as a treatment for episodes of mania in patients with bipolar disorder, according to a systematic review and meta-analysis published in Journal of Psychopharmacology.
Walnut consumers may have lower depression scores
Researchers found a consistent association between eating nuts, particularly walnuts, and fewer and less frequent depressive symptoms in a representative sample of the U.S. population over a 10-year period.
Yoga benefits patients with depression
In a CME article published by Psychiatric Annals, researchers discussed the growing evidence supporting yoga as a beneficial add-on treatment for depression and how mental health practitioners can encourage patients to give it a try.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read